{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:09:09Z","timestamp":1793423349171,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-74-20093"],"award-info":[{"award-number":["21-74-20093"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jmgm.2025.109007","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T19:02:19Z","timestamp":1741460539000},"page":"109007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mangiferin as a potential inhibitor of transthyretin fibrillogenesis"],"prefix":"10.1016","volume":"137","author":[{"given":"Grudinina","family":"N.A","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petukhov","family":"M.G","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokolov","family":"A.V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaldzhyan","family":"A.A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabrodskaya","family":"Y.A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavrilova","family":"N.V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morozkina","family":"S.N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-8962","authenticated-orcid":false,"given":"Egorov","family":"V.V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jmgm.2025.109007_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-291X(02)00465-5","article-title":"Only amyloidogenic intermediates of transthyretin induce apoptosis","volume":"294","author":"Andersson","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"26","key":"10.1016\/j.jmgm.2025.109007_bib2","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"\u00abThe V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2025.109007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105313","article-title":"\u00abTransthyretin: its function and amyloid formation","volume":"155","author":"Ueda","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jmgm.2025.109007_bib4","doi-asserted-by":"crossref","DOI":"10.15275\/rusomj.2021.0416","article-title":"\u00abModern approaches to cardiovascular amyloidosis treatment\u00bb","author":"Morozkina","year":"2021","journal-title":"Russ. Open Med. J."},{"key":"10.1016\/j.jmgm.2025.109007_bib5","unstructured":"FDA approves drug for heart disorder caused by transthyretin-mediated amyloidosis\u00bb, https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-drug-heart-disorder-caused-transthyretin-mediated-amyloidosis."},{"key":"10.1016\/j.jmgm.2025.109007_bib6","article-title":"Attruby (acoramidis), a near complete TTR stabilizer (\u226590%), approved by FDA to reduce cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients","volume":"23","year":"2024","journal-title":"BridgeBio Pharma"},{"issue":"24","key":"10.1016\/j.jmgm.2025.109007_bib7","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jmgm.2025.109007_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1060028019888489","article-title":"Tafamidis: a first-in-class transthyretin stabilizer for transthyretin amyloid cardiomyopathy","volume":"54","author":"Park","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"5","key":"10.1016\/j.jmgm.2025.109007_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/02652048.2016.1216189","article-title":"Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal","volume":"33","author":"Kaur","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jmgm.2025.109007_bib10","unstructured":"\u00abSafety and Efficacy of Tafamidis in Patients with Transthyretin Cardiomyopathy (ATTR-ACT). NCT01994889\u00bb, https:\/\/clinicaltrials.gov\/study\/NCT01994889."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109007_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40265-019-01129-6","article-title":"Tafamidis: a review in transthyretin amyloidosis with polyneuropathy","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jmgm.2025.109007_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109007_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13506129.2019.1643714","article-title":"\u00abA comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy\u00bb","volume":"26","author":"Huber","year":"2019","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109007_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109007_bib15","article-title":"Interaction of the dye Congo red with fibrils of lysozyme, BETA2-MICROGLOBULIN and transthyretin","volume":"58","author":"Antimonova","year":"2016","journal-title":"Tsitologiia"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109007_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2016.1257986","article-title":"\u00abAmyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129509031881","article-title":"Thioflavine t interaction with amyloid \u03b2sheet structures","volume":"2","author":"Levine","year":"1995","journal-title":"Amyloid"},{"key":"10.1016\/j.jmgm.2025.109007_bib18","series-title":"\u00abMangiferin: A Review of Sources and Interventions for Biological Activities\u00bb","author":"Jyotshna","year":"2016"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/biom11010079","article-title":"Mangiferin as new potential anti-cancer agent and mangiferin-integrated polymer systems\u2014a novel research direction","volume":"11","author":"Morozkina","year":"2021","journal-title":"Biomolecules"},{"issue":"SUPPL. 2","key":"10.1016\/j.jmgm.2025.109007_bib20","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.jmgm.2025.109007_bib21","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with attracting cavities and AutoDock vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"48","key":"10.1016\/j.jmgm.2025.109007_bib22","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109007_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1006\/jmbi.1994.1052","article-title":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins","volume":"235","author":"Abagyan","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2025.109007_bib25","doi-asserted-by":"crossref","DOI":"10.1134\/S1990519X24700433","article-title":"Relaxation of steric strains of TTR-type amyloid fibril inhibitors radically changes the results of their virtual screening","author":"Rumyantseva","year":"2024","journal-title":"Cell tissue biol"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120410001667458","article-title":"Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants","volume":"11","author":"Schwarzman","year":"2004","journal-title":"Amyloid"},{"issue":"5259","key":"10.1016\/j.jmgm.2025.109007_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2025.109007_bib28","unstructured":"Coomassie R-250 Staining Protocol\u00bb, https:\/\/www.thermofisher.com\/ru\/ru\/home\/references\/protocols\/proteins-expression-isolation-and-analysis\/staining-protein-gels\/coomassie-staining.html#sol."},{"key":"10.1016\/j.jmgm.2025.109007_bib29","unstructured":"MASCOT Server\u00bb, https:\/\/www.matrixscience.com\/server.html."},{"key":"10.1016\/j.jmgm.2025.109007_bib30","unstructured":"Uniprot\u00bb, https:\/\/www.uniprot.org\/."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2478\/s11534-011-0096-2","article-title":"Gwyddion: an open-source software for SPM data analysis","volume":"10","author":"Ne\u010das","year":"2012","journal-title":"Open Phys."},{"issue":"7","key":"10.1016\/j.jmgm.2025.109007_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.jmgm.2025.109007_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1134\/S1990519X1606002X","article-title":"Interaction of the dye Congo red with fibrils of lysozyme, beta2-microglobulin, and transthyretin","volume":"10","author":"Antimonova","year":"2016","journal-title":"Cell tissue biol"},{"issue":"5","key":"10.1016\/j.jmgm.2025.109007_bib34","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/pr9050852","article-title":"Purification process of mangiferin from Mangifera indica L. Leaves and evaluation of its bioactivities","volume":"9","author":"Loan","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.jmgm.2025.109007_bib35","article-title":"pET system manual","year":"2003","journal-title":"\u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043d\u0430"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109007_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010391","article-title":"Searching for the best transthyretin aggregation protocol to study amyloid fibril disruption","volume":"23","author":"Ferreira","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:15:22Z","timestamp":1763194522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S1093326325000671"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109007","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mangiferin as a potential inhibitor of transthyretin fibrillogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109007"}}